Current Metabolomics
Title:Meet Our Editorial Board Member
Volume: 5 Issue: 2
Author(s): Yumi Zuhanis Has-Yun Hashim
Affiliation:
Export Options
About this article
Cite this article as:
Zuhanis Has-Yun Hashim Yumi , Meet Our Editorial Board Member, Current Metabolomics 2017; 5 (2) . https://dx.doi.org/10.2174/2213235X0502170620075100
DOI https://dx.doi.org/10.2174/2213235X0502170620075100 |
Print ISSN 2213-235X |
Publisher Name Bentham Science Publisher |
Online ISSN 2213-2368 |
14
Related Articles
-
Natural Product Origins of Hsp90 Inhibitors
Current Cancer Drug Targets Cellular Iron Homeostasis and Therapeutic Implications of Iron Chelators in Cancer
Current Pharmaceutical Biotechnology Biologically Active Synthetic Anionophores
Current Organic Chemistry Aptamers Against Cell Surface Receptors: Selection, Modification and Application
Current Medicinal Chemistry Imaging Epigenetics in Alzheimer’s Disease
Current Pharmaceutical Design Carnosine and Lung Disease
Current Medicinal Chemistry Managing Comorbidity in COPD: A Difficult Task
Current Drug Targets Acrylamide Induced Toxicity and the Propensity of Phytochemicals in Amelioration: A Review
Central Nervous System Agents in Medicinal Chemistry The Renin-Angiotensin System: Emerging Concepts
Current Hypertension Reviews STAT3: A Potential Drug Target for Tumor and Inflammation
Current Topics in Medicinal Chemistry Proton Ion-Microbeam Elemental Analysis for Inhaled Particle-Induced Pulmonary Diseases: Application for Diagnosis and Assessment of Progression
Current Medicinal Chemistry Linking Inflammation to Cell Cycle Progression
Current Pharmaceutical Design Nanomaterials for Targeted Delivery of Anticancer Drugs: An Overview
Current Nanomaterials Gold Nanoparticles - Synthesis and Applications in Cancer Management
Recent Patents on Materials Science EGFR(S) Inhibitors in the Treatment of Gastro-Intestinal Cancers: Whats New?
Current Drug Targets Impact of Immunogenetic Polymorphisms in Bone Marrow Failure Syndromes
Mini-Reviews in Medicinal Chemistry Strategies for Targeting the Multidrug Resistance-1 (MDR1)/P-gp Transporter in Human Malignancies
Current Cancer Drug Targets Promises and Challenges of MicroRNA-based Treatment of Multiple Myeloma
Current Cancer Drug Targets Cytochromes P450 in the Bioactivation of Chemicals
Current Topics in Medicinal Chemistry New Insights on Neuronal Nicotinic Acetylcholine Receptors as Targets for Pain and Inflammation: A Focus on α7 nAChRs
Current Neuropharmacology